Sr. Director, Portfolio Positioning & Communications
About GondolaBio
GondolaBio is a standalone rare disease innovator, formed as a spin-out from BridgeBio, with independent governance, capital, and leadership. GondolaBio is focused on developing breakthrough therapeutics for diseases with genetically defined targets. The portfolio includes several clinical-stage programs, with growing franchises across genetic specialties, neurology, and renal. The company leverages cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients, with a purpose-built discovery and development engine. The company is well capitalized, with funding from leading investors.
Who You Are
You are a strategic scientific storyteller who builds conviction through evidence and insight. You bring unusual depth in biology, market dynamics, product strategy, and investor or partner psychology. You can shape the overarching company story and narrative, define differentiated asset value propositions, and help create understanding of entirely new treatment categories. You are a strategic thinker first and an exceptional communicator second: able to challenge assumptions, develop original positioning, and translate complex science into credible, compelling external narratives. You are comfortable working across a decentralized portfolio and directing specialist communications resources as needed.
Key Responsibilities
Corporate and integrated portfolio positioning: Own and continuously refine GondolaBio’s overarching strategic and investment narrative, connecting its differentiated development model, therapeutic franchises, portfolio, and value-creation milestones into one coherent external story.
Asset-level value propositions: Partner with program leaders to develop scientifically grounded, commercially compelling narratives covering unmet need, genetics and biology, patient populations, clinical and regulatory path, competitive differentiation, commercial potential, and key evidence gaps.
New-market development and category shaping: Help define the opportunity for innovative or emerging programs through care pathways, stakeholder insights, evidence requirements, and market-development hypotheses. Work with program teams to define stakeholder engagement along the patient journey.
External stakeholder insight: Structure and synthesize insights from industry partners, investors, KOLs, and external market participants to sharpen positioning, test assumptions, and inform evolving program and franchise strategies, consistent with appropriate scientific and compliance processes.
Partner- and investor-facing materials: Lead corporate, franchise, and asset presentations, pitch decks, executive briefing materials, and other high-stakes content. Adapt the investment case to audiences ranging from potential development partners to investors, without compromising scientific precision.
Conference and signature-event narratives: Define strategic themes and lead substantive content for priority conferences (JPM, Jefferies, BIO, and disease-specific meetings) and curated GondolaBio events (and liaise with shared teams/external providers as needed).
Corporate identity and external communications: Steward message consistency across the website, targeted media, executive communications, digital channels, and external agencies. Set editorial and strategic direction, leveraging external specialist support.
AI-enabled content and insight workflows: Apply advanced AI and digital tools to literature and competitor synthesis, message testing, scientific-content development, and efficient updating of materials, with strong fact-checking, source traceability, and confidentiality practices.
Cross-functional integration: Work closely with program teams, Business Development, Corporate Strategy, and leadership. Use shared scientific and market evidence while owning the narrative and positioning outputs; contribute to cross-functional program and partnering forums.